GF Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.08M Hold
3,302
0.02% 207
2025
Q1
$892K Buy
3,302
+594
+22% +$160K 0.02% 210
2024
Q4
$637K Buy
+2,708
New +$637K 0.01% 215